ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 687793 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 687793; 2) Community: the network communities that were significantly associated with the response to NSC 687793; 3) Molecule: the relationships between components within communities and NSC 687793; 4) MDR: the compounds that were significantly associated with the NSC 687793.

NSC Compound Enrichment Correlation
NSC 674706 Null 0.0352383000003058 0.26416817
NSC 677959 16.beta.-N-methylpiperazino-5-androstene-3.beta.,17.beta.-diol 0.0352383000003058 -0.13296091
NSC 678989 Uracil, 1-[1,2-bis(ethoxycarbonyl)ethenyl]-, cis- 0.0352383000003058 0.24384258
NSC 679002 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl]-, diethyl ester, cis- 0.0352383000003058 0.18760654
NSC 68091 WLN: WS3&1U1SW3 -T 0.0352383000003058 0.32344336
NSC 682298 Camptothecin Derivative 0.0352383000003058 0.2709648
NSC 683332 Spiro[2a,8a-epoxyanthra[2,3-b]oxirene- 2-(1aH),2'-naphtho[1,8-de][1,3]dioxin]-3,8(9H,9aH)-dione, 9-hydroxy-, stereoisomer 0.0352383000003058 0.2593929
NSC 683516 Null 0.0352383000003058 0.28660206
NSC 683518 Null 0.0352383000003058 0.24653092
NSC 645807 ANTINEOPLASTIC-645807 0.0368378753842886 -0.101424
Total:79  Current:60    [First] [Prev] [Next] [Last]